Skip to main content
. Author manuscript; available in PMC: 2014 Jul 10.
Published in final edited form as: Cell Transplant. 2012;21(7):1419–1430. doi: 10.3727/096368911X627480

Figure 2. Expression of MyoD family mRNA in ActRIIB/Fc treated myoblasts.

Figure 2

The total RNA was extracted from control and ActRIIB/Fc treated myoblasts incubated during 2 days without or with recombinant myostatin (500 ng/ml) in the culture medium. The mRNA expression of MyoD (a), Myf5 (b), myogenin (c) and MRF4 (d) was quantified by Q-RT-PCR. ActRIIB/Fc significantly increased the expression of MyoD and myogenin. The data presented are means + SD (n = 3), *p <0.05.